Propellon Therapeutics, Inc. is a company that provides WDR5, Biology, Pharmacy and Therapeutics and more. Propellon Therapeutics, Inc. is headquartered in Canada Ontario. Propellon Therapeutics, Inc. was founded in 2016. Propellon Therapeutics, Inc. has a total of 31 patents
What kind of company is Propellon Therapeutics, Inc.?
Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase...
Where is Propellon Therapeutics, Inc.'s headquarters?